Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

7,511 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Differential clinical features of patients with clinically amyopathic dermatomyositis who have circulating anti-MDA5 autoantibodies with or without myositis-associated autoantibodies.
Yamaguchi K, Yamaguchi A, Kashiwagi C, Sawada Y, Taguchi K, Umetsu K, Oshima K, Uchida M, Suzuki M, Kono S, Takemura M, Masubuchi H, Kitahara S, Hara K, Maeno T, Motegi SI, Muro Y, Sakairi T, Hisada T, Kurabayashi M. Yamaguchi K, et al. Among authors: yamaguchi a. Respir Med. 2018 Jul;140:1-5. doi: 10.1016/j.rmed.2018.05.010. Epub 2018 May 22. Respir Med. 2018. PMID: 29957268 Free article.
Clinical features of patients with anti-melanoma differentiation-associated gene-5 antibody-positive dermatomyositis complicated by spontaneous pneumomediastinum.
Yamaguchi K, Yamaguchi A, Itai M, Kashiwagi C, Takehara K, Aoki S, Sawada Y, Taguchi K, Umetsu K, Oshima K, Uchida M, Takemura M, Hara K, Motegi SI, Muro Y, Nakasatomi M, Sakairi T, Hiromura K, Kurabayashi M, Maeno T. Yamaguchi K, et al. Among authors: yamaguchi a. Clin Rheumatol. 2019 Dec;38(12):3443-3450. doi: 10.1007/s10067-019-04729-5. Epub 2019 Aug 16. Clin Rheumatol. 2019. PMID: 31420814
Clinical features and poor prognostic factors of anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis with rapid progressive interstitial lung disease.
Motegi SI, Sekiguchi A, Toki S, Kishi C, Endo Y, Yasuda M, Ikeuchi H, Sakairi T, Hara K, Yamaguchi K, Maeno T, Hiromura K, Ishikawa O. Motegi SI, et al. Among authors: yamaguchi k. Eur J Dermatol. 2019 Oct 1;29(5):511-517. doi: 10.1684/ejd.2019.3634. Eur J Dermatol. 2019. PMID: 31617496
Clinical features of dermatomyositis associated with anti-MDA5 antibodies by age.
Yamaguchi K, Yamaguchi A, Onuki Y, Itai M, Kashiwagi C, Takehara K, Aoki S, Kanaya A, Taguchi K, Umetsu K, Oshima K, Uchida M, Kimura H, Kasahara M, Takemura M, Hara K, Sekiguchi A, Motegi SI, Muro Y, Nakasatomi M, Motohashi R, Sakairi T, Nakagawa J, Hiromura K, Obokata M, Kurabayashi M, Maeno T. Yamaguchi K, et al. Among authors: yamaguchi a. Mod Rheumatol. 2021 Jan;31(1):177-185. doi: 10.1080/14397595.2020.1740400. Epub 2020 Mar 30. Mod Rheumatol. 2021. PMID: 32149542
Interstitial lung disease with myeloperoxidase-antineutrophil cytoplasmic antibody-associated vasculitis in elderly patients.
Yamaguchi K, Yamaguchi A, Itai M, Onuki Y, Shin Y, Uno S, Hanazato C, Taguchi K, Umetsu K, Aikawa M, Kouno S, Takemura M, Hara K, Motegi S, Tsukida M, Ota F, Tsukada Y, Motegi M, Nakasatomi M, Sakairi T, Ikeuchi H, Kaneko Y, Hiromura K, Maeno T. Yamaguchi K, et al. Among authors: yamaguchi a. Rheumatol Int. 2021 Sep;41(9):1641-1650. doi: 10.1007/s00296-021-04891-7. Epub 2021 May 30. Rheumatol Int. 2021. PMID: 34056682
Quantitative CT analysis of interstitial pneumonia in anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis: a single center, retrospective study.
Yamaguchi K, Nakajima T, Yamaguchi A, Itai M, Onuki Y, Shin Y, Uno S, Muto S, Kouno S, Yatomi M, Aoki-Saito H, Hara K, Endo Y, Motegi SI, Muro Y, Nakasatomi M, Sakairi T, Hiromura K, Katsumata N, Hirasawa H, Tsushima Y, Maeno T. Yamaguchi K, et al. Among authors: yamaguchi a. Clin Rheumatol. 2022 May;41(5):1473-1481. doi: 10.1007/s10067-021-06033-7. Epub 2022 Jan 16. Clin Rheumatol. 2022. PMID: 35034225
Clinical differences among patients with myeloperoxidase-antineutrophil cytoplasmic antibody-positive interstitial lung disease.
Yamaguchi K, Yamaguchi A, Ito M, Wakamatsu I, Itai M, Muto S, Uno S, Aikawa M, Kouno S, Takemura M, Yatomi M, Aoki-Saito H, Koga Y, Hara K, Motegi S, Tsukida M, Ota F, Tsukada Y, Motegi M, Nakasatomi M, Sakairi T, Ikeuchi H, Kaneko Y, Hiromura K, Maeno T. Yamaguchi K, et al. Among authors: yamaguchi a. Clin Rheumatol. 2023 Feb;42(2):479-488. doi: 10.1007/s10067-022-06388-5. Epub 2022 Oct 4. Clin Rheumatol. 2023. PMID: 36194347
Clinical value of 18 F-fluorodeoxyglucose positron emission tomography/computed tomography for interstitial lung disease and myositis in patients with dermatomyositis.
Motegi SI, Fujiwara C, Sekiguchi A, Hara K, Yamaguchi K, Maeno T, Higuchi T, Hirasawa H, Kodaira S, Tomonaga H, Tsushima Y, Ishikawa O. Motegi SI, et al. Among authors: yamaguchi k. J Dermatol. 2019 Mar;46(3):213-218. doi: 10.1111/1346-8138.14758. Epub 2019 Jan 4. J Dermatol. 2019. PMID: 30614031
Influence of obesity in interstitial lung disease associated with anti-aminoacyl-tRNA synthetase antibodies.
Yamaguchi K, Fukushima Y, Yamaguchi A, Itai M, Shin Y, Uno S, Muto S, Kouno S, Tsurumaki H, Yatomi M, Aoki-Saito H, Hara K, Koga Y, Sunaga N, Endo Y, Motegi SI, Nakasatomi M, Sakairi T, Ikeuchi H, Hiromura K, Hisada T, Tsushima Y, Kuwana M, Maeno T. Yamaguchi K, et al. Among authors: yamaguchi a. Respir Med. 2022 Mar;193:106741. doi: 10.1016/j.rmed.2022.106741. Epub 2022 Jan 13. Respir Med. 2022. PMID: 35091206 Free article.
7,511 results